Featured Publications

October 2020

M. Jeyanathan, S. Afkhami, F. Smaill, MS Miller, BD Lichty, Z Xing


M. Sharma M, RG Hart, JW Eikelboom, EM Lonn, S. Yusuf et al.

Nat Rev Immunol





Immunological considerations for COVID-19 vaccine strategies. 2020 Oct;20(10):615-632.




Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy. 2020 Oct;51(10):2901-2909.

September 2020CM Clase, M. Joseph, MB Dolovich et al. Ann Intern MedCloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach.2020 Sep 15;173(6):489-491.
August 2020

G. Pare, M. Sharma, A. Shoamanesh et al. 


D. Arnold, N. Heddle, E. Jamula, W. Lim, J. Kelton, et al.





Lancet Haematol

High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source. 2020 Aug;51(8):2386-2394.



Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. 2020 Sep;7(9):e640-e648.

July 2020M. Zworth, C. Saleh, I. Ball, G. Kalles, S. Oczkowski et al. BMJ OpenProvision of Medical Assistance in Dying: a Scoping Review
2020 Jul 8;10(7):e036054.

June 2020

S. Mithoowani, A. Cervi, N. Shah, E. Sirotich, I. Nazy, D. Arnold et al. 
J Thromb Haemost

Management of Major Bleeds in Patients With Immune Thrombocytopenia. 2020 Jul;18(7):1783-1790.

May 2020

M. Mukherjee, A. Bhalla, J. Cherukat, H. Al-Hayyan, A. Ayoub, P. Nair et. al. Eur Respir J

Sub-optimal Treatment Response to anti-IL-5 Monoclonal Antibodies in Severe Eosinophilic Asthmatics With Airway Autoimmune Phenomena. Eur Respir J. 2020 May 22;2000117.


April 2020

Drs. S. Anand, K. Schulze, K. Teo, S. YusufStrokeReduced Cognitive Assessment Scores Among Individuals With Magnetic Resonance Imaging-Detected Vascular Brain Injury. Stroke. 2020 Apr;51(4):1158-1165.
Dr. I. Walker et al.




Drs. M. Pigeyre, S. Yusuf, H. Gerstein, G. Paré et al.

Lancet Hematology




Diabetes Care

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with Haematological malignancies undergoing transplantation from unrelated donors; final analysis of a randomised, open-label, multicentre, phase 3 trial. Lancet Hematol. 2020 Feb;(7)2:e100-e111.


ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study. Diabetes Care. 2020 Feb 4. pii: dc191973.

Dr. G. Steinberg et al.Nat Rev Drug DiscovAMP-activated protein kinase: the current landscape for drug development. Nat Rev Drug Discov. 2019;18(7):527-551.
Drs. C. Kearon, K. de Wit, S. Schulman, F. Spencer, S. Bates et al.


Drs. A. Patel, F. Borges, G. Guyatt, W. Szczeklik, A. Garg, M. Walsh, S. Yusuf, PJ Devereaux et al.





Ann Intern Med

Diagnosis of Pulmonary Embolism with D-Dimer Adjusted to Clinical Probability. N Engl J Med. 2019 Nov 28;381(22):2125-34.



Preoperative N-Terminal Pro-B Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery. 2020 Jan 21;172(2):96-104.

Drs. H. Gerstein, G. Pare et al.Diabetes CareNovel Biomarkers for Change in Renal Function in People with Dysglycemia. Diabetes Care. Epub 2019 Nov 14.
Drs. JD Schwalm, S. Yusuf et al.





A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomized controlled trial. Lancet. 2019 Oct 5;394(10205):1231-42.
Drs. S. Yusuf, P. Joseph, S. Rangarajan, K. Teo, D. Leong, M. O'Donnell et al.


Drs. S. Mehta, T. Sheth, N. Pinilla-Echeverri et al.






Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. E-pub 2019 Sep 2.


Complete Revascularization with Multivessel PCI for Myocardial Infarction. NEJM. Epub 2019 Sep1.

Dr. H. Gerstein et al. LancetDulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind randomised placebo-controlled trial. Lancet. 2019 Jul 13;394(10193):121-130.